Advanced search

An economic evaluation of clopidogrel vs. aspirin in secondary prevention of ischemic events in high risk atherothrombotic patients in Italy

(2004) VALUE IN HEALTH. 7(6). p.686-687
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Rudelli, G, Lieven Annemans, J Spiesser, M Novelli, A Walker, and S Gabriel. 2004. “An Economic Evaluation of Clopidogrel Vs. Aspirin in Secondary Prevention of Ischemic Events in High Risk Atherothrombotic Patients in Italy.” In Value in Health, 7:686–687.
APA
Rudelli, G., Annemans, L., Spiesser, J., Novelli, M., Walker, A., & Gabriel, S. (2004). An economic evaluation of clopidogrel vs. aspirin in secondary prevention of ischemic events in high risk atherothrombotic patients in Italy. VALUE IN HEALTH (Vol. 7, pp. 686–687). Presented at the ISPOR 7th annual European congress.
Vancouver
1.
Rudelli G, Annemans L, Spiesser J, Novelli M, Walker A, Gabriel S. An economic evaluation of clopidogrel vs. aspirin in secondary prevention of ischemic events in high risk atherothrombotic patients in Italy. VALUE IN HEALTH. 2004. p. 686–7.
MLA
Rudelli, G, Lieven Annemans, J Spiesser, et al. “An Economic Evaluation of Clopidogrel Vs. Aspirin in Secondary Prevention of Ischemic Events in High Risk Atherothrombotic Patients in Italy.” Value in Health. Vol. 7. 2004. 686–687. Print.
@inproceedings{305974,
  author       = {Rudelli, G and Annemans, Lieven and Spiesser, J and Novelli, M and Walker, A and Gabriel, S},
  booktitle    = {VALUE IN HEALTH},
  issn         = {1098-3015},
  language     = {eng},
  location     = {Hamburg, Germany},
  number       = {6},
  pages        = {686--687},
  title        = {An economic evaluation of clopidogrel vs. aspirin in secondary prevention of ischemic events in high risk atherothrombotic patients in Italy},
  url          = {http://dx.doi.org/10.1016/S1098-3015(10)65788-9},
  volume       = {7},
  year         = {2004},
}

Altmetric
View in Altmetric
Web of Science
Times cited: